CART and hematopoietic stem cell co-culture method and system
Through an intelligent system, the co-culture conditions of CART cells and hematopoietic stem cells are optimized, which solves the problems of short maintenance time of CART cells and slow reconstruction of the immune system, and improves the effectiveness of cell therapy and transplant success rate.
Patent Information
- Application Number
- CN202411144063.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-20
- Publication Date
- 2024-11-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
CART cells are maintained in the body for a short time and have insufficient activity, which affects the therapeutic effect. The immune system reconstruction speed after hematopoietic stem cell transplantation is slow, resulting in patients susceptible to infection and transplant failure.
Adopting an intelligent system, including cell preparation module, culture medium optimization module, co-culture condition setting module and cell activity detection module, optimize cell culture conditions through automated equipment and machine learning algorithms, improve the activity and durability of CART cells, and accelerate immunity System reconstruction.
It significantly improves the activity and durability of CART cells, enhances the anti-tumor effect, shortens the immune system reconstruction time, reduces the risk of infection, and improves the efficiency and success rate of cell therapy.
Smart Images

Figure CN118956590A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of hematopoietic stem cell co-culture, and in particular relates to a CART and hematopoietic stem cell co-culture method and system. Background Art
[0002] Hematopoietic stem cell co-culture is an important biotechnology, mainly used to simulate and study the interaction between hematopoietic stem cells and other cell types in vivo. Hematopoietic stem cell co-culture is a method of simulating the interaction between these cells in vivo by co-culturing two or more different types of cells (including at least hematopoietic stem cells) in the same culture medium. This method is widely used in the field of hematopoiesis and provides a powerful tool for studying the functions and interactions of hematopoietic stem cells. However, CART cells have a short maintenance time in the body and are not active enough, which affects the therapeutic effect. After hematopoietic stem cell transplantation, the patient's immune system rebuilds slowly, and infection and transplant failure are prone to occur.
[0003] The existing technology has the following technical problems in hematopoietic stem cell co-culture and CART cell therapy:
[0004] 1. CART cells only last a short time in the body and are not active enough:
[0005] As a type of immunotherapy, the therapeutic effect of CART cells (Chimeric Antigen Receptor T-cells) depends largely on the persistence and activity of CART cells in the body. However, the current problem is that after CART cells are injected into the patient's body, their maintenance time is relatively short, and the activity of the cells is often insufficient. This directly affects the ability of CART cells to kill tumor cells, thereby reducing the therapeutic effect.
[0006] 2. Slow reconstruction of the immune system after hematopoietic stem cell transplantation:
[0007] Hematopoietic stem cell transplantation (HSCT) is an important treatment, especially in certain blood system diseases and immunodeficiency diseases. However, the problem with current technology is that the patient's immune system is often rebuilt slowly after receiving a hematopoietic stem cell transplant. This causes the patient to have low immunity for a period of time after the transplant, making them susceptible to various infections and even leading to transplant failure. This slow rate of immune system reconstruction is an important problem that current technology needs to solve.
[0008] In summary, in order to enhance the effect of CART cell therapy and improve the reconstruction of the immune system after hematopoietic stem cell transplantation, technical innovation and improvement are needed to address the above issues. For example, the persistence and activity of CART cells in the body can be improved by optimizing the culture and transduction methods of CART cells; at the same time, research can also be conducted on how to accelerate the reconstruction of the immune system after hematopoietic stem cell transplantation, reduce the risk of infection in patients, and improve the success rate of transplantation. Summary of the invention
[0009] In response to the problems existing in the prior art, the present invention provides a method and system for co-culturing CART and hematopoietic stem cells.
[0010] The present invention is implemented as follows: an intelligent system for co-culturing CART and hematopoietic stem cells, the system comprising:
[0011] The cell preparation module includes a cell separator, a cell counter, and an automatic pipetting workstation, which are used to automatically separate, purify, and count CART cells and hematopoietic stem cells, and accurately dispense cell suspensions;
[0012] The media optimization module includes a high-throughput media screening system and a liquid handling robot, which is used to optimize the media composition through machine learning algorithms and automatically prepare and distribute the optimized media;
[0013] The co-culture condition setting module includes an automatic incubator and an environmental monitoring system, which is used to control and monitor the temperature, humidity and CO2 concentration of the culture environment in real time to ensure the optimization of culture conditions;
[0014] The co-culture process monitoring module includes a co-culture system, an automated microscope, and data analysis software to continuously monitor cell growth, observe cell morphology changes in real time, and analyze cell growth and interactions;
[0015] The cell activity detection module includes a flow cytometer, an automated microplate reader, and a data management system, which is used to automatically detect the activity and metabolic status of cells after co-culture and generate a detailed analysis report.
[0016] The present invention also provides an intelligent method for realizing co-culture of CART and hematopoietic stem cells, comprising the following steps:
[0017] Cell preparation: Use a cell separator to automatically separate and purify CART cells and hematopoietic stem cells, use a cell counter to detect the number of cells, and use an automatic pipetting workstation to accurately dispense the cell suspension into the culture container;
[0018] Culture medium optimization: A high-throughput culture medium screening system uses machine learning algorithms to optimize culture medium composition, and a liquid handling robot automatically prepares and distributes culture medium based on the optimization results;
[0019] Co-culture condition setting: Use an automatic incubator to control and maintain the most suitable environmental conditions for co-culture. The environmental monitoring system uses sensors to monitor and adjust the temperature, humidity and CO2 concentration inside the incubator in real time;
[0020] Co-culture process: The co-culture system starts the co-culture process, the automatic microscope takes cell images at regular intervals, and the data analysis software processes and analyzes the image data to generate cell growth curves and interaction maps;
[0021] Cell activity detection: Use flow cytometry to automatically detect the activity of cells after co-culture, and use an automated microplate reader to detect cell metabolic activity. The data management system integrates the detection data and generates an analysis report.
[0022] Further, the cell preparation method:
[0023] (1) Extracting CART cells and hematopoietic stem cells;
[0024] (2) Cell pretreatment: washing, counting and necessary purification steps.
[0025] Further, the culture medium is optimized;
[0026] Screening of culture medium ingredients: Experiment with different combinations of ingredients to select the best formula;
[0027] Test the culture medium ratio: Determine the optimal ratio of each component and find the culture medium most suitable for co-culture of CART and hematopoietic stem cells through experiments.
[0028] Further, the co-cultivation conditions are set;
[0029] Temperature control: Set the culture environment temperature, usually 37°C;
[0030] Humidity control: maintain proper humidity to prevent cells from drying out;
[0031] Oxygen concentration adjustment: adjust the oxygen concentration, usually 510% of CO2 concentration.
[0032] Further, the co-cultivation process;
[0033] Mix CART cells and hematopoietic stem cells in appropriate proportions;
[0034] Place the cell mixture in optimized culture medium;
[0035] Under the regulation of the co-culture condition control module, in vitro co-culture is performed.
[0036] Further, the cell activity detection;
[0037] Take samples regularly and use the cell activity detection module for real-time monitoring;
[0038] Assess cell proliferation, differentiation, activity, and functional status;
[0039] Record and analyze data to ensure the efficacy of co-culture.
[0040] Another object of the present invention is to provide a CART and hematopoietic stem cell co-culture system comprising:
[0041] The medium optimization module is used to test different medium components using high-throughput screening technology; determine the optimal ratio of components through experiments; and dynamically adjust the medium components according to cell status and needs;
[0042] The co-culture condition control module is used to use a constant temperature incubator to ensure stable temperature; use humidity sensors and regulators to maintain appropriate humidity; and be equipped with a gas mixing system to accurately control the concentration of oxygen and carbon dioxide;
[0043] The cell activity detection module is equipped with a microscope and flow cytometer detection equipment to monitor cell activity in real time; automatically record monitoring data and analyze it through software; and evaluate the functional status of CART and hematopoietic stem cells, including proliferation rate, cell activity and immune regulation function.
[0044] Another object of the present invention is to provide a computer device, comprising a memory and a processor, wherein the memory stores a computer program, and when the computer program is executed by the processor, the processor executes the steps of the CART and hematopoietic stem cell co-culture method.
[0045] Another object of the present invention is to provide a computer-readable storage medium storing a computer program, which, when executed by a processor, enables the processor to perform the steps of the CART and hematopoietic stem cell co-culture method.
[0046] Another object of the present invention is to provide an information data processing terminal, which is used to implement the CART and hematopoietic stem cell co-culture system.
[0047] In combination with the above technical solutions and the technical problems solved, the advantages and positive effects of the technical solutions to be protected by the present invention are as follows:
[0048] First, by optimizing the culture medium and co-culture conditions, we can achieve efficient co-culture of CART cells and hematopoietic stem cells in vitro, enhance cell activity and persistence, and increase the speed of immune reconstruction after transplantation. The co-culture system ensures the successful implementation of the co-culture process through precise environmental control and real-time cell monitoring.
[0049] The co-culture method significantly improved the activity and persistence of CART cells and enhanced the anti-tumor effect.
[0050] It enhances the immunoregulatory function of hematopoietic stem cells, accelerates the reconstruction of the patient's immune system after transplantation, and reduces the risk of infection.
[0051] The co-culture system improves the efficiency and success rate of cell therapy and the treatment of blood diseases by optimizing culture conditions.
[0052] Second, the present invention aims to solve several key problems in the co-culture method of CART and hematopoietic stem cells in the prior art. Traditional co-culture methods usually rely on manual operation, with complex processes and easily affected by human factors, resulting in low repeatability and reliability of experimental results. In addition, traditional methods make it difficult to monitor cell growth and interaction in real time, and it is impossible to adjust culture conditions in time to optimize experimental results, which limits the in-depth research and the wide promotion of clinical applications.
[0053] The present invention realizes the full automation and real-time monitoring of CART and hematopoietic stem cell co-culture by introducing intelligent equipment and software systems. The efficiency and accuracy of cell preparation are significantly improved by using cell separators, cell counters and automatic pipetting workstations; high-throughput culture medium screening systems and liquid handling robots optimize the selection and preparation of culture media; automatic incubators and environmental monitoring systems ensure the stability and adaptability of the culture environment; automatic microscopes and data analysis software realize real-time monitoring and analysis of cell growth and interactions. Through these technological advances, the present invention has achieved significant improvements in efficiency, accuracy and experimental repeatability.
[0054] The method of the present invention not only realizes the automation and intelligence of the co-cultivation process, but also introduces a machine learning algorithm to optimize the culture medium composition and experimental conditions, thereby improving the personalization and adaptability of the experiment. Through real-time processing and analysis of experimental data by data analysis software, it is possible to quickly identify and respond to abnormal conditions during the culture process, dynamically adjust experimental conditions, and ensure the optimization of the experiment. In addition, the present invention has also made significant progress in cell activity detection, and has achieved efficient and accurate cell activity detection through flow cytometry and automated microplate reader, generating detailed analysis reports, and providing reliable data support for subsequent research.
[0055] The present invention has not only achieved important breakthroughs at the technical level, but also brought significant social and economic benefits. Through the automated and intelligent co-culture method, the experimental efficiency and reliability of the results are significantly improved, and the errors and costs caused by manual operation are reduced. The application of this technology will promote the progress of CART and hematopoietic stem cell research, accelerate its application in clinical treatment, and improve the treatment effect and quality of life of patients. In addition, the intelligent experimental method provides efficient and reliable tools for scientific researchers in related fields, promotes scientific research and innovation, and has broad application prospects and market value. BRIEF DESCRIPTION OF THE DRAWINGS
[0056] Figure 1 It is a flow chart of the co-culture method of CART and hematopoietic stem cells provided in an embodiment of the present invention.
[0057] Figure 2 It is a flow chart of the cell preparation method provided by an embodiment of the present invention.
[0058] Figure 3 It is a structural block diagram of the CART and hematopoietic stem cell co-culture system provided in an embodiment of the present invention.
[0059] Figure 4 It is a bar chart comparing the embodiment of the present invention with the prior art.
[0060] Figure 5 The experimental efficiency of the traditional method and the automated method over time was compared. It can be seen that the automated method is more efficient and stable, while the traditional method is affected by noise and variation and shows large fluctuations.
[0061] Figure 6 The reliability of results from the traditional and automated methods was compared. The automated method provided more reliable and consistent results, while the traditional method showed more fluctuations and noise. DETAILED DESCRIPTION
[0062] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0063] like Figure 1 As shown, a method for co-culturing CART and hematopoietic stem cells provided in an embodiment of the present invention comprises the following steps:
[0064] S101, cell preparation;
[0065] S102, culture medium optimization;
[0066] S103, co-culture condition setting;
[0067] S104, co-culture process;
[0068] S105, cell activity detection.
[0069] Intelligent technical solution for the co-culture of CART and hematopoietic stem cells.
[0070] In order to realize the intelligent co-culture method of CART and hematopoietic stem cells, it is necessary to combine specific equipment, software and hardware to ensure the automation and efficiency of each step. The following is a specific implementation plan:
[0071] Step 1: Cell preparation
[0072] Equipment and hardware and software:
[0073] Cell separator: used to automatically separate and purify CART cells and hematopoietic stem cells.
[0074] Cell Counter: Automatically count the number of cells to ensure consistent initial cell concentration.
[0075] Automatic pipetting workstation: used for precise dispensing of cell suspensions.
[0076] Intelligent process:
[0077] 1. Use a cell separator to separate CART cells and hematopoietic stem cells, and automatically purify and concentrate the cells.
[0078] 2. Detect the number of cells by cell counter and automatically adjust the cell concentration.
[0079] 3. The automatic pipetting workstation dispenses the cell suspension into culture plates or culture bottles to ensure the consistency of each experimental repetition.
[0080] Step 2: Media Optimization
[0081] Equipment and hardware and software:
[0082] High-throughput culture medium screening system: used to screen the best culture medium combination.
[0083] Liquid handling robots: Automated preparation of culture media.
[0084] Intelligent process:
[0085] 1. The high-throughput culture medium screening system optimizes the culture medium composition through machine learning algorithms to find the culture medium formula that is most suitable for co-culture of CART cells and hematopoietic stem cells.
[0086] 2. The liquid handling robot automatically prepares the culture medium based on the optimization results and distributes it to each culture container.
[0087] Step 3: Co-culture Condition Setup
[0088] Equipment and hardware and software:
[0089] Automatic incubator: controls temperature, humidity and CO2 concentration.
[0090] Environmental monitoring system: monitor and adjust culture conditions in real time.
[0091] Intelligent process:
[0092] 1. The automated incubator sets and maintains the most optimal environmental conditions for co-culture.
[0093] 2. The environmental monitoring system uses sensors to monitor the internal environment of the incubator, such as temperature, humidity and CO2 concentration, in real time, and automatically adjusts as needed.
[0094] Step 4: Co-cultivation process
[0095] Equipment and hardware and software:
[0096] Co-cultivation system: integrated cultivation, monitoring and data logging functions.
[0097] Automated microscope: observe cell morphology changes in real time.
[0098] Data analysis software: Analyze cell growth and interactions.
[0099] Intelligent process:
[0100] 1. After the co-culture system sets up the cells and culture medium, it automatically starts the co-culture process and continuously monitors the cell growth.
[0101] 2. The automated microscope takes cell images at regular intervals to monitor cell morphological changes and interactions.
[0102] 3. Data analysis software processes and analyzes image data to generate growth curves and interaction maps.
[0103] Step 5: Cell viability assay
[0104] Equipment and hardware and software:
[0105] Flow cytometry: Detect cell surface markers and activity.
[0106] Automated microplate reader: measure cellular metabolic activity.
[0107] Data management system: integrates test data and provides analysis reports.
[0108] Intelligent process:
[0109] 1. Use flow cytometry to automatically detect cell activity after co-culture and analyze surface markers of CART cells and hematopoietic stem cells.
[0110] 2. Automated microplate reader detects the metabolic activity of cells, such as glucose consumption and lactate production.
[0111] 3. The data management system integrates all test data and generates detailed analysis reports, including cell activity, proliferation and metabolic status.
[0112] The overall architecture of the intelligent system:
[0113] 1. Central control system: coordinate and control the operation of all equipment to ensure seamless connection of each step.
[0114] 2. Database management system: stores and manages all experimental data, and supports data query and analysis.
[0115] 3. User interface: Provides a friendly operation interface to facilitate users to set experimental parameters and view experimental progress.
[0116] 4. Artificial Intelligence Module: Use machine learning and deep learning algorithms to optimize experimental conditions and analyze experimental results.
[0117] Through the combination of the above intelligent equipment and software and hardware, the CART and hematopoietic stem cell co-culture method of the present invention can achieve efficient, accurate and automated operation, significantly improving the experimental efficiency and the reliability of the results.
[0118] like Figure 2 As shown, the cell preparation method provided by the embodiment of the present invention is:
[0119] S201, extraction of CART cells and hematopoietic stem cells;
[0120] S202, cell pretreatment: washing, counting and necessary purification steps.
[0121] The culture medium optimization provided by the embodiments of the present invention;
[0122] Screening of culture medium ingredients: Experiment with different combinations of ingredients to select the best formula;
[0123] Test the culture medium ratio: Determine the optimal ratio of each component and find the culture medium most suitable for co-culture of CART and hematopoietic stem cells through experiments.
[0124] The co-cultivation condition setting provided in the embodiment of the present invention;
[0125] Temperature control: Set the culture environment temperature, usually 37°C;
[0126] Humidity control: maintain proper humidity to prevent cells from drying out;
[0127] Oxygen concentration adjustment: adjust the oxygen concentration, usually 510% of CO2 concentration.
[0128] The co-cultivation process provided by the embodiments of the present invention;
[0129] Mix CART cells and hematopoietic stem cells in appropriate proportions;
[0130] Place the cell mixture in optimized culture medium;
[0131] Under the regulation of the co-culture condition control module, in vitro co-culture is performed.
[0132] The cell activity detection provided by the embodiment of the present invention;
[0133] Take samples regularly and use the cell activity detection module for real-time monitoring;
[0134] Assess cell proliferation, differentiation, activity, and functional status;
[0135] Record and analyze data to ensure the efficacy of co-culture.
[0136] like Figure 3 As shown, a CART and hematopoietic stem cell co-culture system provided by an embodiment of the present invention includes:
[0137] The medium optimization module is used to test different medium components using high-throughput screening technology; determine the optimal ratio of components through experiments; and dynamically adjust the medium components according to cell status and needs;
[0138] The co-culture condition control module is used to use a constant temperature incubator to ensure stable temperature; use humidity sensors and regulators to maintain appropriate humidity; and be equipped with a gas mixing system to accurately control the concentration of oxygen and carbon dioxide;
[0139] The cell activity detection module is equipped with a microscope and flow cytometer detection equipment to monitor cell activity in real time; automatically record monitoring data and analyze it through software; and evaluate the functional status of CART and hematopoietic stem cells, including proliferation rate, cell activity and immune regulation function.
[0140] The working principle of a CART and hematopoietic stem cell co-culture system provided in an embodiment of the present invention is as follows:
[0141] First, the working principle of the culture medium optimization module:
[0142] 1. Use high-throughput screening technology to test different culture medium components. This technology can quickly and efficiently evaluate the effects of various components on the growth of CART cells and hematopoietic stem cells.
[0143] 2. Determine the optimal ratio of ingredients through experiments. This step is to find the most suitable culture medium formula for co-culture of CART cells and hematopoietic stem cells to promote cell growth and function.
[0144] 3. Dynamically adjust the composition of the culture medium according to the cell status and needs. This means that the system will continuously monitor the status of the cells and adjust the composition of the culture medium according to the actual situation to ensure that the cells are always in the best growth environment.
[0145] Second, the working principle of the co-culture condition control module:
[0146] 1. Use a constant temperature incubator to ensure stable temperature. A constant temperature environment is essential for the normal growth of cells, so the system uses a constant temperature incubator to provide stable temperature conditions.
[0147] 2. Use humidity sensors and regulators to maintain proper humidity. Humidity is one of the important factors affecting cell growth. The system monitors humidity in real time through humidity sensors and adjusts humidity to an appropriate level through regulators.
[0148] 3. Equipped with a gas mixing system to accurately control the concentration of oxygen and carbon dioxide. The gas composition has an important influence on cell respiration and metabolism. The system accurately controls the gas composition in the culture environment through the gas mixing system to meet the growth needs of CART cells and hematopoietic stem cells.
[0149] Third, the working principle of the cell activity detection module:
[0150] 1. Equipped with microscopes and flow cytometers to monitor cell activity in real time. These devices can visually observe changes in cell morphology and quantity, and assess cell activity.
[0151] 2. Automatically record monitoring data and analyze it through software. The system automatically records the data of each test and analyzes and processes the data through software so that researchers can understand the growth and functional status of cells in a timely manner.
[0152] 3. Evaluate the functional status of CART and hematopoietic stem cells. This includes evaluating the proliferation rate, cell activity, and immune regulation of cells. Through these evaluations, researchers can understand the impact of the co-culture system on the function of CART cells and hematopoietic stem cells, thereby further optimizing the culture conditions and improving the therapeutic effect of cells.
[0153] Another object of the present invention is to provide a computer device, comprising a memory and a processor, wherein the memory stores a computer program, and when the computer program is executed by the processor, the processor executes the steps of the CART and hematopoietic stem cell co-culture method.
[0154] Another object of the present invention is to provide a computer-readable storage medium storing a computer program, which, when executed by a processor, enables the processor to perform the steps of the CART and hematopoietic stem cell co-culture method.
[0155] Another object of the present invention is to provide an information data processing terminal, which is used to implement the CART and hematopoietic stem cell co-culture system.
[0156] Example 1: Co-culture of CART cells and hematopoietic stem cells in optimized culture medium
[0157] By optimizing the culture medium components, the co-culture efficiency of CART cells and hematopoietic stem cells can be improved, the activity and persistence of CART cells can be enhanced, and the immunoregulatory function of hematopoietic stem cells can be promoted.
[0158] 1. Cell Preparation
[0159] Extract human CART cells and hematopoietic stem cells.
[0160] Cell washing, counting and purification.
[0161] 2. Culture medium optimization
[0162] Component screening: RPMI1640 culture medium was used as the base, and different concentrations of fetal bovine serum (FBS), interleukin 2 (IL2), interleukin 7 (IL7) and interleukin 15 (IL15) were added for screening experiments.
[0163] Ratio optimization: The optimal component ratio was determined through cell proliferation experiments, such as 10% FBS, 100 IU / ml IL2, 10 ng / ml IL7 and 10 ng / ml IL15.
[0164] 3. Co-culture Conditions Setup
[0165] Temperature setting: 37℃
[0166] Humidity setting: 95%
[0167] Oxygen concentration setting: 5% CO2
[0168] 4. Co-culture Process
[0169] CART cells and hematopoietic stem cells were mixed in a 1:1 ratio.
[0170] The mixed cells were placed in an optimized culture medium and co-cultured in an incubator for 14 days.
[0171] 5. Cell Viability Detection
[0172] Samples were taken every 2 days, and cell proliferation rate and activity were detected using flow cytometry.
[0173] The cell activity was detected using the MTT method.
[0174] Record and analyze cell proliferation and viability data.
[0175] After co-culture in optimized culture medium, the activity and persistence of CART cells were significantly improved, and the immunoregulatory function of hematopoietic stem cells was also enhanced.
[0176] Example 2: Co-culture of CART cells and hematopoietic stem cells under dynamic control co-culture conditions
[0177] By dynamically adjusting the co-culture conditions, the co-culture effect of CART cells and hematopoietic stem cells can be improved, and cell activity and function can be enhanced.
[0178] 1. Cell Preparation
[0179] Extract human CART cells and hematopoietic stem cells.
[0180] Cell washing, counting and purification.
[0181] 2. Culture medium optimization
[0182] Use optimized culture medium ingredients (such as the optimal formula determined in Example 1).
[0183] 3. Co-culture Conditions Setup
[0184] Using the co-culture condition control module, set the initial conditions: temperature 37°C, humidity 95%, oxygen concentration 5% CO2.
[0185] Dynamic regulation: Dynamically adjust oxygen concentration and temperature according to the cell growth status. For example: on the 7th day of co-culture, adjust the oxygen concentration to 10%.
[0186] 4. Co-culture Process
[0187] CART cells and hematopoietic stem cells were mixed in a 1:1 ratio.
[0188] The mixed cells were placed in an optimized culture medium and co-cultured in an incubator for 14 days.
[0189] During the co-cultivation period, the culture conditions were adjusted according to the real-time monitoring data.
[0190] 5. Cell Viability Detection
[0191] Real-time monitoring: Flow cytometry and microscopy were used to monitor cell activity and proliferation every day.
[0192] Data recording and analysis: Automatically record monitoring data and analyze cell proliferation rate and activity through software.
[0193] result
[0194] By dynamically adjusting the co-culture conditions, the co-culture effect of CART cells and hematopoietic stem cells is significantly improved, the activity and persistence of CART cells are further enhanced, and the immune regulation function of hematopoietic stem cells is also better exerted.
[0195] These two examples demonstrate specific methods for achieving efficient co-culture of CART cells and hematopoietic stem cells and improving cell activity and function by optimizing the culture medium and dynamically adjusting the co-culture conditions.
[0196] In order to realize the intelligent method of co-culturing CART and hematopoietic stem cells, the following is the specific program implementation of each step, using Python programming language and commonly used scientific computing and data processing libraries.
[0197] #Step 1: Cell preparation
[0198] Use Python to write code to control cell separators, cell counters, and automated pipetting workstations.
[0199] ```Python
[0200] import time
[0201] import numpy as np
[0202] from lab_equipment import CellSeparator,CellCounter,LiquidHandler
[0203] # Initialize the device
[0204] separator = CellSeparator()
[0205] counter = CellCounter()
[0206] handler = LiquidHandler()
[0207] #Cell Isolation and Purification
[0208] cart_cells=separator.separate('CART')
[0209] stem_cells=separator.separate('Stem')
[0210] #Count cells and adjust concentration
[0211] cart_count=counter.count(cart_cells)
[0212] stem_count=counter.count(stem_cells)
[0213] cart_cells_adjusted=separator.adjust_concentration(cart_cells,target_count=1e6)
[0214] stem_cells_adjusted=separator.adjust_concentration(stem_cells,target_count=1e6)
[0215] # Aliquot cell suspension
[0216] handler.dispense(cart_cells_adjusted,volume_per_well=100,wells=96)
[0217] handler.dispense(stem_cells_adjusted,volume_per_well=100,wells=96)
[0218] ```
[0219] #Step 2: Media Optimization
[0220] Use high-throughput screening systems and liquid handling robotics to optimize and formulate culture media.
[0221] ```Python
[0222] from machine_learning import MediaOptimizer
[0223] from lab_equipment import LiquidHandler
[0224] # Initialize the device and optimizer
[0225] optimizer = MediaOptimizer()
[0226] handler = LiquidHandler()
[0227] # Culture medium optimization
[0228] optimal_media=optimizer.optimize(['media1','media2','media3'],cart_cells,stem_cells)
[0229] #Prepare culture medium
[0230] handler.prepare_media(optimal_media)
[0231] handler.distribute_media(optimal_media,wells=96)
[0232] ```
[0233] #Step 3: Co-culture Conditions Setup
[0234] Use an automated incubator and environmental monitoring system to set up co-culture conditions.
[0235] ```Python
[0236] fromincubator import AutomatedIncubator
[0237] # Initialize the incubator and environmental monitoring system
[0238] incubator=AutomatedIncubator()
[0239] #Set culture conditions
[0240] incubator.set_temperature(37)
[0241] incubator.set_humidity(95)
[0242] incubator.set_co2_level(5)
[0243] #Real-time monitoring of culture conditions
[0244] while True:
[0245] incubator.monitor_conditions()
[0246] time.sleep(60)#Monitor once every minute
[0247] ```
[0248] #Step 4: Co-cultivation process
[0249] Use a co-culture system, automated microscope, and data analysis software to monitor the co-culture process.
[0250] ```Python
[0251] from microscopy import AutomatedMicroscope
[0252] from data_analysis import ImageAnalyzer
[0253] # Initialize microscope and analysis software
[0254] microscope=AutomatedMicroscope()
[0255] analyzer = ImageAnalyzer()
[0256] #Start the co-cultivation process
[0257] incubator.start_coculture(cart_cells_adjusted,stem_cells_adjusted,optimal_media)
[0258] #Timed cell image capture
[0259] forhour in range(0,72,6):#Shoot once every 6 hours for 72 hours
[0260] images=microscope.capture_images()
[0261] analyzer.analyze(images)
[0262] time.sleep(21600)#wait for 6 hours
[0263] ```
[0264] #Step 5: Cell viability assay
[0265] Use flow cytometry, automated microplate readers, and data management systems to monitor cell viability and generate reports.
[0266] ```Python
[0267] from flow_cytometry import FlowCytometer
[0268] fromplate_readerimport AutomatedPlateReader
[0269] from data_management import DataManager
[0270] # Initialize the device
[0271] cytometer = FlowCytometer()
[0272] plate_reader=AutomatedPlateReader()
[0273] data_manager = DataManager()
[0274] # Detect cell activity
[0275] flow_results=cytometer.analyze(cart_cells_adjusted)
[0276] metabolic_results=plate_reader.measure_metabolism(cart_cells_adjusted)
[0277] #Integrate test data and generate reports
[0278] data_manager.integrate_data(flow_results,metabolic_results)
[0279] data_manager.generate_report()
[0280] ```
[0281] Through the above-mentioned specific procedures, the CART and hematopoietic stem cell co-culture method of the present invention can achieve a high degree of automation and intelligence. The combination of equipment and software in each step ensures the efficiency and accuracy of the experimental process. The following is a summary of the main functions of each module:
[0282] Cell preparation: Use a cell separator, cell counter, and automated pipetting workstation to ensure standardization and consistency of cell preparation.
[0283] Culture medium optimization: Use high-throughput culture medium screening systems and liquid handling robots to optimize culture medium formulations and improve culture effects.
[0284] Co-culture condition setting: Automatic incubator and environmental monitoring system ensure the best co-culture environment and adjust culture conditions in real time.
[0285] Co-culture process: Automated microscopy and data analysis software monitor cell growth in real time and analyze cell interactions.
[0286] Cell activity detection: Flow cytometer and automated microplate reader detect cell activity, and the data management system generates a detailed analysis report.
[0287] Through these intelligent technical solutions, the efficiency of co-culture of CART and hematopoietic stem cells and the reliability of results can be significantly improved, promoting the development of related research and applications.
[0288] Columnar Figure 4 The comparison of four key indicators under the traditional method and the method of the present invention is shown, which is standardized to the 0100 interval for a more intuitive comparison.
[0289] #Chart interpretation:
[0290] 1. Cell preparation time:
[0291] The method of the present invention (green column) significantly shortens the cell preparation time and greatly improves the efficiency compared to the traditional method (blue column).
[0292] 2. Culture medium optimization effect:
[0293] The method of the present invention has achieved remarkable progress in the culture medium optimization effect, and the success rate has been greatly improved.
[0294] 3. Experimental repeatability:
[0295] The method of the present invention significantly reduces the standard deviation of the experimental results and improves the repeatability and reliability of the experimental results.
[0296] 4. Accuracy of cell activity detection:
[0297] The method of the present invention significantly improves the accuracy of cell activity detection and provides more reliable data support for subsequent research.
[0298] Through this bar chart, we can intuitively see the significant advantages of the present invention in various technical indicators.
[0299] The following two graphs show the key effects of the present invention:
[0300] 1. Experimental efficiency: the first curve Figure 5 The experimental efficiency of the traditional method and the automated method over time was compared. It can be seen that the automated method is more efficient and stable, while the traditional method is affected by noise and variation and shows large fluctuations.
[0301] 2. Result reliability: the second curve Figure 6 The reliability of results from the traditional and automated methods was compared. The automated method provided more reliable and consistent results, while the traditional method showed more fluctuations and noise.
[0302] These curves show the significant improvements in experimental efficiency and result reliability achieved by introducing automation and intelligent systems. The above is only a specific implementation of the present invention, but the protection scope of the present invention is not limited thereto. Any modification, equivalent substitution and improvement made by any technician familiar with the technical field within the technical scope disclosed by the present invention and within the spirit and principle of the present invention shall be covered within the protection scope of the present invention.
Claims
1. An intelligent system for co-culturing CART hematopoietic stem cells, characterized in that: The system includes: The cell preparation module includes a cell separator, a cell counter, and an automatic pipetting workstation, which are used to automatically separate, purify, and count CART cells and hematopoietic stem cells, and accurately dispense cell suspensions; The culture medium optimization module includes a high-throughput culture medium screening system and a liquid handling robot, which is used to optimize culture medium composition through machine learning algorithms and automatically prepare and distribute the optimized culture medium; The co-culture condition setting module includes an automatic incubator and an environmental monitoring system, which is used to control and monitor the temperature, humidity, and CO2 concentration of the culture environment in real time to ensure the optimization of culture conditions; The co-culture process monitoring module includes a co-culture system, an automated microscope, and data analysis software to continuously monitor cell growth, observe cell morphology changes in real time, and analyze cell growth and interactions; The cell activity detection module, which includes a flow cytometer, an automated microplate reader, and a data management system, is used to automatically detect the activity and metabolic status of cells after co-culture and generate detailed analysis reports.
2. An intelligent method for co-culturing CART and hematopoietic stem cells, characterized in that: The following steps are involved: Cell preparation: Use a cell separator to automatically separate and purify CART cells and hematopoietic stem cells, use a cell counter to detect the cell number, and use an automated pipetting workstation to accurately dispense the cell suspension into culture containers; Culture medium optimization: A high-throughput culture medium screening system uses machine learning algorithms to optimize culture medium composition, and liquid handling robots automatically prepare and distribute culture medium based on the optimization results; Co-culture condition setting: Use an automatic incubator to control and maintain the most suitable environmental conditions for co-culture. The environmental monitoring system uses sensors to monitor and adjust the temperature, humidity and CO2 concentration inside the incubator in real time; Co-culture process: The co-culture system starts the co-culture process, the automated microscope takes cell images at regular intervals, and the data analysis software processes and analyzes the image data to generate cell growth curves and interaction maps; Cell viability assay: Flow cytometry is used to automatically detect cell viability after co-culture, and an automated microplate reader is used to detect cell metabolic activity. The data management system integrates the assay data and generates an analysis report.
3. The method for co-culturing CART and hematopoietic stem cells according to claim 2, wherein: The cell preparation method: (1) Extraction of CART cells and hematopoietic stem cells; (2) Cell pretreatment: washing, counting and necessary purification steps.
4. The method for co-culturing CART and hematopoietic stem cells according to claim 2, wherein: The culture medium is optimized; Screening of culture medium ingredients: Experiment with different combinations of ingredients to select the best formula; Test the culture medium ratio: Determine the optimal ratio of each component and find the culture medium most suitable for co-culture of CART and hematopoietic stem cells through experiments.
5. The method for co-culturing CART and hematopoietic stem cells according to claim 2, wherein: The co-cultivation condition setting; Temperature control: Set the culture environment temperature, usually 37°C; Humidity control: maintain proper humidity to prevent cells from drying out; Oxygen concentration adjustment: adjust the oxygen concentration, usually 510% of CO2 concentration.
6. The method for co-culturing CART and hematopoietic stem cells according to claim 2, wherein: the co-cultivation process; Mix CART cells and hematopoietic stem cells in appropriate proportions; Place the cell mixture in optimized culture medium; Under the regulation of the co-culture condition control module, in vitro co-culture is performed.
7. The method for co-culturing CART and hematopoietic stem cells according to claim 2, wherein: The cell activity detection; Take samples regularly and use the cell activity detection module for real-time monitoring; Assess cell proliferation, differentiation, activity, and functional status; Record and analyze data to ensure the effectiveness of co-culture.
8. A CART and hematopoietic stem cell co-culture system for implementing the CART and hematopoietic stem cell co-culture method according to any one of claims 27, characterized in that: The CART and hematopoietic stem cell co-culture system includes: The medium optimization module is used to test different medium components using high-throughput screening technology; determine the optimal ratio of components through experiments; and dynamically adjust the medium composition according to cell status and needs; The co-culture condition control module is used to ensure stable temperature using a constant temperature incubator; maintain appropriate humidity using a humidity sensor and regulator; and be equipped with a gas mixing system to precisely control oxygen and carbon dioxide concentrations; The cell activity detection module is equipped with a microscope and flow cytometer to monitor cell activity in real time; automatically record monitoring data and analyze it through software; and evaluate the functional status of CART and hematopoietic stem cells, including proliferation rate, cell activity, and immune regulation function.
9. A computer-readable storage medium storing a computer program, which, when executed by a processor, causes the processor to perform the steps of the method for co-culturing CART and hematopoietic stem cells as described in any one of claim 16.
10. An information data processing terminal, characterized in that: The information data processing terminal is used to implement the CART and hematopoietic stem cell co-culture system as described in claim 7.
Citation Information
Cited By
Stem cell-oriented culture environment real-time monitoring method and system
CN119736161A
